SPL ASX Chart
Snapshot
Starpharma Holdings Limited (SPL) is an advisor in dendrimer technology for medical applications. As an Australian biopharmaceutical company, Starpharma is focused on developing and commercializing therapeutic products that address global healthcare needs.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -56.09% |
vs ASX 200 (1yr) | -46.56% |
Announcements
Corporate Overview
Corporate Details
Head Office | Abbotsford VIC 3067 |
Website | www.starpharma.com |
Registry | Computershare |
Auditor | PricewaterhouseCoopers |
Date Listed | 28 Sep 2000 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2025 | Report (Interim) |
21/08/2025 | Report (Prelim) |
21/08/2025 | Report (Annual) |
Former Company Names
- Starpharma Pooled Development Limited (SPL), 20/04/2004.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
SPL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of SPL directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
ICM Investment Management Ltd | 14/08/2024 | 33,066,682 | 8.00 |
Allianz SE and the entities | 14/08/2024 | 48,480,000 | 11.81 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
14-08-24 | UIL Limited | 5,500,000 | 6.69 | 8.02 |
26-06-24 | UIL Limited | 8,520,682 | 5.12 | 6.69 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
05-09-24 | Allan Gray Australia Pty Ltd | 23,690,480 | 5.74 | -- |
23-08-24 | Allan Gray Australia Pty Ltd | 4,248,017 | 6.78 | 5.74 |
31-07-24 | Allan Gray Australia Pty Ltd | 4,661,466 | 7.91 | 6.78 |
28-06-24 | Allan Gray Australia Pty Ltd | 5,639,737 | 9.28 | 7.91 |
21-06-24 | Allan Gray Australia Pty Ltd | 5,351,615 | 10.58 | 9.28 |
14-05-24 | Allan Gray Australia Pty Ltd | 4,229,661 | 11.65 | 10.58 |
19-10-23 | M&G Investment Management Limited | 20,747,400 | 5.05 | -- |
18-10-23 | M&G Investment Management Limited | 7,111,812 | 6.81 | 5.05 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.095 | 28 June |
2023 | $0.31 | 30 June |
2022 | $0.74 | 30 June |
2021 | $1.50 | 30 June |
2020 | $1.13 | 30 June |
2019 | $1.36 | 28 June |
2018 | $1.17 | 29 June |
2017 | $0.73 | 30 June |
2016 | $0.645 | 30 June |
2015 | $0.73 | 30 June |
2014 | $0.58 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.